Myriad Genetics, Inc.MYGNNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P29
Within normal range
vs 2Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-1.56%
202411.21%
202311.03%
2022-1.77%
202123.99%
2020-12.78%
2019-24.97%
201810.16%
20170.16%
20162.33%